Battling Lung Cancer with Immunotherapy

[MUSIC] Every morning I go on a mile and half hike just to get my day
started on the right foot. Before I was diagnosed I lived
a very healthy life, and then suddenly, I was spitting
up a little bit of blood. So I contacted my primary
care physician and was ordered to get to
an emergency room right away. Sure enough, the CT scan identified a mass
in my left lung. They had diagnosed me with stage
four adenocarcinoma lung cancer. I was told that I had nine
months to live without treatment, 18 months to
live with treatment. And then I would begin
a regimen of four to six chemotherapy treatments
the following week. A CT scan after
the fourth cycle showed that the chemotherapy
was not working. My regional expert hospital
referred me to Hopkins for an immunotherapy clinical trial
in hopes that I would have some life saving chance there.>>When I first met Mr.
Ryan he was hoping to get onto a clinical trial
with immunotherapy. Immune therapy is any
therapy that we use to manipulate your own immune
system to attack the cancer. This particular trial was
just for patients with metastatic lung cancer who
had previous chemotherapy.>>I was chosen to
participate in the anti-PD-1 immunotherapy drug
arm of the trial. I would have a Infusion
every two weeks and a CT scan every six weeks. After four cycles
of immunotherapy, my tumor had shrunk 65%. And subsequent immunotherapy
infusions, my tumor shrank and I came to an eight or
a low point of an 82% shrink. And I’ve remained at that
stable condition to date through 71 infusions
of immunotherapy drug.>>His disease actually
responded beautifully to the immune therapy,
and hes done well. And the cancer has
remained under control for a very long period of time for
years.>>The more treatments I have means the less likely that I
will have disease progression.>>Clinical trials
give people hope. You know research really
goes give patients hope, and the fact that we’re hoping for
improved quality of life, better survival, and we’re still trying
to really strive for a cure.>>Having access to
immunotherapy is truly a game changer, a life saver. I am grateful beyond
all measure for what she has accomplished, and what she has made available to
patients with terminal disease. Where it be greater thinking
is that if a patient can endure two years of
immunotherapy, the likelihood is to die of something
other than that cancer. Which from someone on the pointy
end of the spear is exceedingly good news and an exceedingly
rich source of hope. [MUSIC]